Candriam Equities L Oncology Impact I/ LU1864482358 /
| NAV22/05/2024 | Var.-0.9199 | Type of yield | Focus sugli investimenti | Società d'investimento |
|---|---|---|---|---|
| 2,876.3101USD | -0.03% | reinvestment | Equity Worldwide | Candriam ▶ |
Performance mensile
| gen | feb | mar | apr | mag | giu | lug | ago | set | ott | nov | dic | Totale | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 | - | - | - | - | - | - | - | - | - | - | - | -6.00 | - |
| 2019 | 10.25 | 6.19 | 2.66 | -3.64 | -2.56 | 8.69 | 0.30 | -0.28 | -3.18 | 5.10 | 7.96 | 5.03 | +41.52% |
| 2020 | -1.46 | -5.35 | -3.07 | 12.12 | 8.54 | 1.42 | 4.43 | 2.15 | 3.52 | -2.21 | 5.82 | 3.86 | +32.43% |
| 2021 | 0.55 | -4.20 | -0.09 | 2.33 | 0.17 | 3.53 | -0.96 | 5.58 | -3.77 | 3.37 | -6.37 | 3.99 | +3.43% |
| 2022 | -10.49 | -1.75 | 4.65 | -5.85 | -1.33 | 0.04 | 4.37 | -3.14 | -4.71 | 7.04 | 6.07 | -3.44 | -9.67% |
| 2023 | 2.16 | -3.88 | 1.38 | 2.83 | -2.56 | 0.08 | 0.89 | -2.02 | -5.25 | -6.36 | 9.21 | 5.73 | +1.11% |
| 2024 | 1.37 | 4.14 | 1.49 | -3.38 | 4.75 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 mesi | 1 anno | 3 anni | 5 anni | |
|---|---|---|---|---|---|
| Volatilità | 10.73% | 10.88% | 11.74% | 14.70% | 17.25% |
| Indice di Sharpe | 1.83 | 3.16 | 0.19 | -0.17 | 0.39 |
| Mese migliore | +5.73% | +9.21% | +9.21% | +9.21% | +12.12% |
| Mese peggiore | -3.38% | -3.38% | -6.36% | -10.49% | -10.49% |
| Perdita massima | -6.77% | -6.77% | -15.90% | -25.08% | -25.08% |
| Outperformance | +19.13% | - | +25.64% | - | - |
Tutte le quotazioni in USD
Tranches
| Nome | Type of yield | Prezzo di riacquisto | 1 anno | 3 anni | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,394.5100 | +6.40% | +4.89% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,559.5100 | +6.53% | +5.28% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.3400 | +2.88% | -5.91% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,236.3701 | +3.53% | +15.65% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,606.9301 | +6.06% | +3.88% | |
| Candriam Equities L Oncology Imp... | reinvestment | 245.5600 | +4.48% | +13.34% | |
| Candriam Equities L Oncology Imp... | paying dividend | 235.6100 | +5.06% | +1.01% | |
| Candriam Equities L Oncology Imp... | paying dividend | 190.8000 | +5.96% | +3.58% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,775.0000 | +1.86% | +1.35% | |
| Candriam Equities L Oncology Imp... | reinvestment | 158.2100 | +3.41% | +15.26% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,108.2300 | +3.85% | -3.22% | |
| Candriam Equities L Oncology Imp... | reinvestment | 260.2100 | +5.36% | +16.25% | |
| Candriam Equities L Oncology Imp... | reinvestment | 206.8100 | +2.47% | -7.02% | |
| Candriam Equities L Oncology Imp... | reinvestment | 286.1000 | +5.95% | +3.57% | |
| Candriam Equities L Oncology Imp... | reinvestment | 193.6300 | +3.73% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,844.6801 | +3.87% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,876.3101 | +6.06% | +3.88% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.8700 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 273.7400 | +5.06% | +0.99% |
Prestazione
| YTD | +8.43% | ||
|---|---|---|---|
| 6 mesi | +17.39% | ||
| 1 anno | +6.06% | ||
| 3 anni | +3.88% | ||
| 5 anni | +65.36% | ||
| 10 anni | - | ||
| Dall'inizio | +91.82% | ||
| Anno | |||
| 2023 | +1.11% | ||
| 2022 | -9.67% | ||
| 2021 | +3.43% | ||
| 2020 | +32.43% | ||
| 2019 | +41.52% | ||
